BioMarin Pharmaceuticals BMRN Price / earnings

Price / earnings at other companies

Sarepta Therapeutics, Inc.SRPT

35.1×—

PTC TherapeuticsPTCT

6.5×—

Zevra Therapeutics, Inc.ZVRA

14.5×-175×

Agios PharmaceuticalsAGIO

3.7×—

XER

Xeris Biopharma Holdings, Inc.XERS

83.3×—

Krystal Biotech, Inc.KRYS

33.6×-8.3×

FAQ

What is BioMarin Pharmaceuticals's price / earnings?

BioMarin Pharmaceuticals (BMRN) reported price / earnings of 20× in Q3 2025.

How has BioMarin Pharmaceuticals's price / earnings changed year-over-year?

BioMarin Pharmaceuticals's price / earnings decreased by 51.9% year-over-year, from 41.5× to 20×.

What is the long-term trend for BioMarin Pharmaceuticals's price / earnings?

Over 3 years (2020 to 2024), BioMarin Pharmaceuticals's price / earnings has grown at a 15.9% compound annual growth rate (CAGR), from 18.9× to 29.3×.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.